Author/Authors :
Acevedo، نويسنده , , Victor D. and Gangula، نويسنده , , Rama D. and Freeman، نويسنده , , Kevin W. and Li، نويسنده , , Rile and Zhang، نويسنده , , Youngyou and Wang، نويسنده , , Fen and Ayala، نويسنده , , Gustavo E. and Peterson، نويسنده , , Leif E. and Ittmann، نويسنده , , Michael and Spencer، نويسنده , , David M.، نويسنده ,
Abstract :
Summary
last Growth Factor Receptor-1 (FGFR1) is commonly overexpressed in advanced prostate cancer (PCa). To investigate causality, we utilized an inducible FGFR1 (iFGFR1) prostate mouse model. Activation of iFGFR1 with chemical inducers of dimerization (CID) led to highly synchronous, step-wise progression to adenocarcinoma that is linked to an epithelial-to-mesenchymal transition (EMT). iFGFR1 inactivation by CID withdrawal led to full reversion of prostatic intraepithelial neoplasia, whereas PCa lesions became iFGFR1-independent. Gene expression profiling at distinct stages of tumor progression revealed an increase in EMT-associated Sox9 and changes in the Wnt signaling pathway, including Fzd4, which was validated in human PCa. The iFGFR1 model clearly implicates FGFR1 in PCa progression and demonstrates how CID-inducible models can help evaluate candidate molecules in tumor progression and maintenance.
